Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGIO | 43.33% | $2.05B | +53.42% | 0.00% |
ARCT | 41.28% | $513.31M | -44.59% | 0.00% |
CORT | 37.02% | $5.42B | +110.64% | 0.00% |
FWRD | 33.49% | $926.83M | -44.64% | 0.00% |
KIRK | 32.74% | $21.64M | -42.11% | 0.00% |
SPCE | 29.39% | $170.37M | -87.17% | 0.00% |
SMLR | 28.66% | $465.13M | +0.62% | 0.00% |
KRO | 26.92% | $1.05B | -4.01% | 5.42% |
HUBS | 26.09% | $36.62B | +24.48% | 0.00% |
SUNS | 25.17% | $91.97M | +17.52% | 4.70% |
USM | 24.50% | $5.25B | +48.18% | 0.00% |
SA | 23.25% | $1.08B | +7.39% | 0.00% |
ITRN | 23.21% | $661.33M | +19.74% | 4.98% |
HIMS | 23.08% | $5.62B | +198.15% | 0.00% |
STEP | 22.40% | $4.41B | +89.90% | 1.55% |
DUOL | 22.35% | $14.21B | +49.79% | 0.00% |
PSLV | 22.32% | - | - | 0.00% |
ARLO | 22.10% | $1.19B | +27.50% | 0.00% |
PAAS | 22.10% | $7.78B | +42.65% | 1.86% |
SW | 21.48% | $27.01B | +12.35% | 1.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EPC | -19.47% | $1.57B | -13.78% | 1.89% |
JKHY | -19.29% | $12.65B | +3.48% | 1.28% |
UEIC | -19.13% | $133.15M | +18.01% | 0.00% |
FLUT | -19.09% | $45.56B | +57.13% | 0.00% |
CRVL | -18.44% | $5.63B | +40.36% | 0.00% |
MOMO | -18.41% | $910.30M | +15.44% | 0.00% |
OFLX | -18.26% | $389.14M | -45.01% | 3.54% |
CME | -18.06% | $82.63B | +15.91% | 4.55% |
CELH | -17.80% | $6.82B | -51.48% | 0.00% |
DKNG | -15.95% | $18.70B | +14.24% | 0.00% |
DNB | -15.71% | $5.13B | +0.26% | 1.75% |
CBOE | -15.66% | $20.20B | +9.90% | 1.22% |
PEP | -15.11% | $201.05B | -12.21% | 3.74% |
FIS | -14.67% | $42.72B | +27.06% | 1.86% |
TSN | -14.25% | $19.37B | +1.76% | 3.60% |
DLTH | -13.93% | $103.07M | -44.08% | 0.00% |
PNR | -13.10% | $16.44B | +40.61% | 0.94% |
AEG | -13.09% | $9.47B | +4.54% | 5.85% |
MKTX | -12.98% | $8.28B | -19.26% | 1.37% |
NOC | -12.95% | $67.34B | -2.06% | 1.76% |
Yahoo
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today provided an update on the Company's commercial and clinical programs and its outlook for 2025. These updates will be discussed as part of the Company's presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT (6:00 p.m. ET).
Finnhub
BRIDGEWATER - Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases,...
Yahoo
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 19 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
Yahoo
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT/6:00 p.m. ET.
Yahoo
We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this […]
Yahoo
We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other biotech stocks. The Booming Biotechnology Sector The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and […]
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UVSP | -<0.01% | $836.15M | +39.83% | 3.04% |
UTZ | <0.01% | $1.17B | -14.66% | 1.74% |
STZ | -<0.01% | $39.81B | -13.93% | 2.07% |
TPVG | -0.01% | $272.08M | - | 18.45% |
NTZ | 0.01% | $53.64M | -24.50% | 0.00% |
HFWA | 0.01% | $812.17M | +17.43% | 4.03% |
SWBI | 0.01% | $436.51M | -25.69% | 5.19% |
VTR | 0.01% | $24.44B | +19.77% | 3.13% |
SYPR | 0.02% | $48.81M | -0.47% | 0.00% |
UVE | -0.02% | $556.39M | +20.70% | 3.35% |
GEN | 0.02% | $16.71B | +18.80% | 1.87% |
PGC | 0.02% | $539.17M | +7.81% | 0.69% |
BZUN | 0.03% | $163.06M | +29.07% | 0.00% |
SMWB | 0.04% | $1.21B | +164.12% | 0.00% |
FSLY | 0.04% | $1.32B | -46.81% | 0.00% |
DFIN | 0.04% | $1.72B | -1.33% | 0.00% |
EPD | 0.05% | $70.32B | +20.59% | 6.43% |
TLYS | -0.05% | $129.05M | -40.88% | 0.00% |
NTIC | -0.06% | $127.19M | +9.19% | 2.13% |
CTAS | -0.06% | $77.70B | +31.27% | 2.44% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QQA | 47.09% | $144.94M | 0% |
RSPA | 43.59% | $270.13M | 0% |
EFAA | 27.84% | $104.22M | 0% |
SLVP | 19.32% | $219.11M | 0.39% |
SILJ | 17.02% | $880.74M | 0.69% |
XBI | 16.83% | $6.39B | 0.35% |
SIL | 16.08% | $1.10B | 0.65% |
GDXJ | 15.68% | $4.60B | 0.52% |
GDX | 14.80% | $13.08B | 0.51% |
CMDY | 14.66% | $282.97M | 0.28% |
IPO | 14.45% | $157.80M | 0.6% |
PTH | 14.43% | $122.57M | 0.6% |
FTGC | 14.43% | $2.24B | 1.02% |
FBCG | 14.37% | $3.94B | 0.59% |
XPH | 14.14% | $158.74M | 0.35% |
DBMF | 14.08% | $1.27B | 0.85% |
FFOG | 14.07% | $121.65M | 0.55% |
ARGT | 14.04% | $1.07B | 0.59% |
GOAU | 13.77% | $89.28M | 0.6% |
GCC | 13.67% | $131.62M | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPYV | 0.01% | $24.65B | 0.04% |
SPYD | 0.03% | $6.59B | 0.07% |
IHDG | -0.03% | $2.79B | 0.58% |
FDL | -0.05% | $4.49B | 0.45% |
EMB | -0.05% | $13.33B | 0.39% |
IBDT | 0.06% | $2.45B | 0.1% |
MOAT | 0.06% | $15.13B | 0.46% |
DBEU | 0.07% | $570.90M | 0.45% |
FLMI | -0.07% | $428.40M | 0.3% |
BGRN | 0.08% | $394.26M | 0.2% |
SCHY | 0.09% | $799.60M | 0.14% |
EEMV | -0.10% | $4.03B | 0.25% |
HYMU | 0.10% | $255.43M | 0.35% |
CXSE | 0.10% | $374.56M | 0.32% |
SUB | 0.10% | $8.65B | 0.07% |
PBJ | -0.11% | $99.20M | 0.62% |
EWQ | 0.13% | $472.68M | 0.5% |
LMBS | 0.13% | $4.69B | 0.64% |
SMIG | 0.14% | $765.48M | 0.6% |
XLI | -0.14% | $20.34B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BIL | -12.39% | $36.56B | 0.1356% |
CCOR | -11.65% | $83.85M | 1.18% |
IYK | -9.59% | $1.22B | 0.4% |
EPHE | -9.22% | $95.76M | 0.59% |
TBIL | -9.08% | $4.78B | 0.15% |
GOVZ | -8.79% | $269.61M | 0.1% |
SHV | -8.23% | $19.11B | 0.15% |
PREF | -7.95% | $1.06B | 0.55% |
EDV | -7.95% | $3.75B | 0.06% |
FXG | -7.79% | $358.25M | 0.63% |
SCHQ | -7.71% | $689.53M | 0.03% |
ENZL | -7.66% | $77.54M | 0.5% |
ZROZ | -7.60% | $1.50B | 0.15% |
TLTW | -7.17% | $953.16M | 0.35% |
VRIG | -6.95% | $1.13B | 0.3% |
FTXG | -6.90% | $22.63M | 0.6% |
VGLT | -6.81% | $9.63B | 0.04% |
IGRO | -6.59% | $903.49M | 0.15% |
LTPZ | -6.43% | $679.38M | 0.2% |
TLT | -6.30% | $49.84B | 0.15% |
Current Value
$63.621 Year Return
Current Value
$63.621 Year Return